Cargando…

Evidence for context-dependent functions of KDM5B in prostate development and prostate cancer

Prostate cancer (PCa) is one of the leading causes of cancer-related deaths worldwide. Prostate tumorigenesis and PCa progression involve numerous genetic as well as epigenetic perturbations. Histone modification represents a fundamental epigenetic mechanism that regulates diverse cellular processes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Bigang, Kumar, Rahul, Chao, Hseuh-Ping, Mehmood, Rashid, Ji, Yibing, Tracz, Amanda, Tang, Dean G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679033/ https://www.ncbi.nlm.nih.gov/pubmed/33245716 http://dx.doi.org/10.18632/oncotarget.27818

Ejemplares similares

LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Li, Qiuhui, et al.
Publicado: (2019)

Author Correction: LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer
por: Li, Qiuhui, et al.
Publicado: (2020)

Intron retention is a hallmark and spliceosome represents a therapeutic vulnerability in aggressive prostate cancer
por: Zhang, Dingxiao, et al.
Publicado: (2020)

The KDM5B and KDM1A lysine demethylases cooperate in regulating androgen receptor expression and signalling in prostate cancer
por: Metzler, Veronika M., et al.
Publicado: (2023)

Linking prostate cancer cell AR heterogeneity to distinct castration and enzalutamide responses
por: Li, Qiuhui, et al.
Publicado: (2018)

Transgenic overexpression of NanogP8 in the mouse prostate is insufficient to initiate tumorigenesis but weakly promotes tumor development in the Hi-Myc mouse model
por: Liu, Bigang, et al.
Publicado: (2017)

Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT
por: Lemster, Anna-Lena, et al.
Publicado: (2022)

Targeting USP1‐dependent KDM4A protein stability as a potential prostate cancer therapy
por: Cui, Shu‐Zhong, et al.
Publicado: (2020)

Histone 2B-GFP Label-Retaining Prostate Luminal Cells Possess Progenitor Cell Properties and Are Intrinsically Resistant to Castration
por: Zhang, Dingxiao, et al.
Publicado: (2017)

KDM5D predicts response to docetaxel chemotherapy in metastatic castration resistant prostate cancer patients
por: Schäfer, Georg, et al.
Publicado: (2021)

Kdm6b Regulates Context-Dependent Hematopoietic Stem Cell Self-Renewal and Leukemogenesis
por: Mallaney, Cates, et al.
Publicado: (2019)

Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy
por: Tapping, Charles R, et al.
Publicado: (2019)

MicroRNA-141 suppresses prostate cancer stem cells and metastasis by targeting a cohort of pro-metastasis genes
por: Liu, Can, et al.
Publicado: (2017)

NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation
por: Jeter, Collene R., et al.
Publicado: (2011)

Dissociated Primary Human Prostate Cancer Cells Coinjected with the Immortalized Hs5 Bone Marrow Stromal Cells Generate Undifferentiated Tumors in NOD/SCID-γ Mice
por: Chen, Xin, et al.
Publicado: (2013)

The histone demethylase KDM3A regulates the transcriptional program of the androgen receptor in prostate cancer cells
por: Wilson, Stephen, et al.
Publicado: (2017)

Hypoxia Stimulates SUMOylation-Dependent Stabilization of KDM5B
por: Zhou, Bingluo, et al.
Publicado: (2021)

MicroRNA 100: a context dependent miRNA in prostate cancer
por: Leite, Katia R. M., et al.
Publicado: (2013)

KDM4B as a Target for Prostate Cancer: Structural Analysis and Selective Inhibition by a Novel Inhibitor
por: Chu, Chia-Han, et al.
Publicado: (2014)

Defining Young in the Context of Prostate Cancer
por: Chambers, Suzanne K., et al.
Publicado: (2015)

The EP300, KDM5A, KDM6A and KDM6B Chromatin Regulators Cooperate with KLF4 in the Transcriptional Activation of POU5F1
por: Wang, Wan-Ping, et al.
Publicado: (2012)

NANOG reprograms prostate cancer cells to castration resistance via dynamically repressing and engaging the AR/FOXA1 signaling axis
por: Jeter, Collene R, et al.
Publicado: (2016)

Drawing a line between histone demethylase KDM5A and KDM5B: their roles in development and tumorigenesis
por: Yoo, Jung, et al.
Publicado: (2022)

Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc
por: Lin, Ching-Yu, et al.
Publicado: (2019)

Investigation of Histone Lysine-Specific Demethylase 5D (KDM5D) Isoform Expression in Prostate Cancer Cell Lines: a System Approach
por: Jangravi, Zohreh, et al.
Publicado: (2016)

Regenerative technology to restore and preserve erectile function in men following prostate cancer treatment: evidence for penile rehabilitation in the context of prostate cancer survivorship
por: Chung, Eric
Publicado: (2021)

Systematic characterization of chromatin modifying enzymes identifies KDM3B as a critical regulator in castration resistant prostate cancer
por: Saraç, Hilal, et al.
Publicado: (2019)

Targeting KDM4B that coactivates c-Myc-regulated metabolism to suppress tumor growth in castration-resistant prostate cancer
por: Wu, Meng-Jen, et al.
Publicado: (2021)

miR-199a-3p targets stemness-related and mitogenic signaling pathways to suppress the expansion and tumorigenic capabilities of prostate cancer stem cells
por: Liu, Ruifang, et al.
Publicado: (2016)

Inhibition of KDM4C/c‐Myc/LDHA signalling axis suppresses prostate cancer metastasis via interference of glycolytic metabolism
por: Lin, Ching‐Yu, et al.
Publicado: (2022)

BAZ2A-RNA mediated association with TOP2A and KDM1A represses genes implicated in prostate cancer
por: Roganowicz, Marcin, et al.
Publicado: (2023)

Transitory masculinities in the context of being sick with prostate cancer
por: Araújo, Jeferson Santos, et al.
Publicado: (2019)

LRIG1, a regulator of stem cell quiescence and a pleiotropic feedback tumor suppressor
por: Ji, Yibing, et al.
Publicado: (2022)

ETV4 mediates dosage-dependent prostate tumor initiation and cooperates with p53 loss to generate prostate cancer
por: Li, Dan, et al.
Publicado: (2023)

Histone Lysine Demethylases KDM5B and KDM5C Modulate Genome Activation and Stability in Porcine Embryos
por: Glanzner, Werner Giehl, et al.
Publicado: (2020)

KDM5A and KDM5B histone-demethylases contribute to HU-induced replication stress response and tolerance
por: Gaillard, Solenne, et al.
Publicado: (2021)

Molecular determinants of prostate cancer metastasis
por: Rycaj, Kiera, et al.
Publicado: (2017)

Activation of the KDM5A/miRNA-495/YTHDF2/m6A-MOB3B axis facilitates prostate cancer progression
por: Du, Chen, et al.
Publicado: (2020)

Androgen receptor reprogramming demarcates prognostic, context-dependent gene sets in primary and metastatic prostate cancer
por: Severson, Tesa, et al.
Publicado: (2022)

Regulation of KDM5C stability and enhancer reprogramming in breast cancer
por: Xiao, Qiong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_im82kn1l4n94mg03j46khcnc34